Holistic healing

Brophy, Beth
August 1993
U.S. News & World Report;8/9/93, Vol. 115 Issue 6, p20
Reports that Mutual of Omaha, America's largest provider of health care insurance for individuals, announced it will reimburse patients who try to reverse heart disease by taking part in a program that combines diet, exercise, meditation and support groups. Brief information on the `reversal program' developed by Dr. Dean Ornish; Probability that other insurers will cover similar programs.


Related Articles

  • SERUM URIC ACID AND CAD: A CONNECTION?  // Cortlandt Forum;02/25/2001, Vol. 14 Issue 2, p84 

    Focuses on the benefits of losartan against coronary artery disease. Uric acid in patients with insulin resistance.

  • Early Invasive Treatment in Patients with Unstable CAD. Walling, Anne D. // American Family Physician;2/1/2000, Vol. 61 Issue 3, p797 

    Discusses research on early invasive treatment in patients with unstable coronary artery disease. Reference to a study from the August 28, 1999 issue of the `Lancet'; Incidence of Myocardial ischemia; Studies conducted on patients with coronary ischemia; Application of invasive treatment to the...

  • Save your life.  // Body Bulletin;Jan1993, p2 

    Discusses why responding quickly to a heart attack is more important than ever now. The new class of clot-busting drugs; How they can actually stop many heart attacks in their tracks and prevent virtually any damage to the heart muscle; Quick delivery; Take an aspirin before you go to the...

  • Yo-yo, no-no.  // Current Health 2;Feb1992, Vol. 18 Issue 6, p23 

    Discusses the health risks of yo-yo dieting. A Yale University study which found that people who had large weight fluctuations over a 32-year period were more likely to develop heart disease; Lost fat and muscle regained only as fat.

  • In defense of imbibing.  // Executive Health's Good Health Report;Jun93, Vol. 29 Issue 9, p8 

    Cites a study which reveals certain regions in France have low incidence of atherosclerosis and heart disease despite a high intake of saturated fatty acids and cholesterol. French paradox; Link to wine consumption at moderate levels; Study to determine how wine's non-alcoholic components...

  • Clot-busting drugs to `turn off' heart... Carey, C. // FDA Consumer;Feb1988, Vol. 22 Issue 1, p22 

    Heart attacks are deadly because they're brought on by clots that block the blood supply to the heart muscle. Growing use of clot-dissolving drugs gives a greater chance of recovery from a heart attack.

  • When we dead awaken. H.L.N. // Hastings Center Report;Jan/Feb92, Vol. 22 Issue 1, p3 

    Discusses a study which reviewed the records over a nineteenth-month period of 185 patients who suffered cardiac arrest in a nonhospital setting. Nonhospital attempts at resuscitation for these patients by an emergency medical team were unsuccessful. Data concerning those who were...

  • Angioplasty: Unsuccessful, unproven, and growing in popularity.  // HealthFacts;May93, Vol. 18 Issue 168, p1 

    Discusses the reasons why angioplasty is being subjected to a serious rethinking. Purpose of angioplasty; Findings from clinical trial; Explanations by cardiologist Thomas B. Graboy; Three categories of prescription drugs for angina; Estimate; Diet. INSETS: What does Angina feel like?...

  • No adequate predictors to guide the treatment of post-TIA stroke.  // Modern Medicine;Nov94, Vol. 62 Issue 11, p63 

    Presents an abstract of an article entitled `Factors Affecting Survival and Occurrence of Stroke in Patients With Transient Ischemic Attacks,' by B.A. Evans, J.D. Sciks and J.P. Whisnant in the May 1994 issue of the `Mayo Clinical Proceedings,' about the lack of adequate predictors to guide the...

  • ...and, long term, it improves survival for those with heart disease.  // Modern Medicine;Feb95, Vol. 63 Issue 2, p46 

    Presents an abstract of the article `Randomized Trial of Cholesterol Lowering in 4,444 Patients with Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4s),' by the Scandinavian Simvastatin Survival Study Group from the periodical `The Lancet,' dated November 19, 1994.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics